As with CYP2E1, there are substantial inter-ethnic differences in CYP2D6 across populations, ranging from complete loss of function or reduction in functional activity (2570% of the population, dependent on ethnic origin and geographical location) to extensive, ultra-rapid metabolisers (1.59.3% of the population) (see Table 3 in the supplementary data for a summary of the evidence) [17, 38]
A., & Thomas, J
Weeks 1 through 4: 0.25mg per week (1mg total used over 4 weeks) Weeks 5 through 8: 0.5mg per week (2mg total used over 4 weeks) Weeks 9 through 12: 1.0mg per week (4mg total used over 4 weeks) Weeks 13 through 16: 1.7mg per week (6.8mg total used over 4 weeks) Week 17 onward: 2.4mg per week (maintenance dose) During the first four weeks at 0.25mg weekly, you use only 1mg from your 10mg vial
Why GHK-Cu Works Better Systemically (Not Just Topically) While GHK-Cu is commonly found in serums and post-procedure products, systemic delivery allows it to work beyond the surface of the skin
Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children
PMID: 298 MoreiraICAmaralIDominguesICardosoACardosoMJCardosoJS